FDA Announces Approval of Blood and Blood Component Regulations Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and `Lookback'" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.